OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Vesicle trafficking and lipid metabolism in synucleinopathy
Saranna Fanning, Dennis J. Selkoe, Ulf Dettmer
Acta Neuropathologica (2020) Vol. 141, Iss. 4, pp. 491-510
Open Access | Times Cited: 35
Saranna Fanning, Dennis J. Selkoe, Ulf Dettmer
Acta Neuropathologica (2020) Vol. 141, Iss. 4, pp. 491-510
Open Access | Times Cited: 35
Showing 1-25 of 35 citing articles:
Lipid droplets in the nervous system
Isha Ralhan, Chi‐Lun Chang, Jennifer Lippincott‐Schwartz, et al.
The Journal of Cell Biology (2021) Vol. 220, Iss. 7
Open Access | Times Cited: 152
Isha Ralhan, Chi‐Lun Chang, Jennifer Lippincott‐Schwartz, et al.
The Journal of Cell Biology (2021) Vol. 220, Iss. 7
Open Access | Times Cited: 152
Advances in understanding the function of alpha-synuclein: implications for Parkinson’s disease
Paolo Calabresi, Giulia Di Lazzaro, Gioia Marino, et al.
Brain (2023) Vol. 146, Iss. 9, pp. 3587-3597
Open Access | Times Cited: 60
Paolo Calabresi, Giulia Di Lazzaro, Gioia Marino, et al.
Brain (2023) Vol. 146, Iss. 9, pp. 3587-3597
Open Access | Times Cited: 60
Energy metabolism in health and diseases
Hui Liu, Shuo Wang, Jianhua Wang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Hui Liu, Shuo Wang, Jianhua Wang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Modeling neurodegeneration in Caenorhabditis elegans
Kim A. Caldwell, Corey W. Willicott, Guy A. Caldwell
Disease Models & Mechanisms (2020) Vol. 13, Iss. 10
Open Access | Times Cited: 119
Kim A. Caldwell, Corey W. Willicott, Guy A. Caldwell
Disease Models & Mechanisms (2020) Vol. 13, Iss. 10
Open Access | Times Cited: 119
The 3D structure of lipidic fibrils of α-synuclein
Benedikt Frieg, Leif Antonschmidt, Christian Dienemann, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 65
Benedikt Frieg, Leif Antonschmidt, Christian Dienemann, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 65
More than meets the eye in Parkinson’s disease and other synucleinopathies: from proteinopathy to lipidopathy
Manuel Flores‐León, Tiago F. Outeiro
Acta Neuropathologica (2023) Vol. 146, Iss. 3, pp. 369-385
Open Access | Times Cited: 25
Manuel Flores‐León, Tiago F. Outeiro
Acta Neuropathologica (2023) Vol. 146, Iss. 3, pp. 369-385
Open Access | Times Cited: 25
Large-scale proteomic analyses of incident Parkinson’s disease reveal new pathophysiological insights and potential biomarkers
Yi‐Han Gan, Lingzhi Ma, Yi Zhang, et al.
Nature Aging (2025)
Closed Access | Times Cited: 1
Yi‐Han Gan, Lingzhi Ma, Yi Zhang, et al.
Nature Aging (2025)
Closed Access | Times Cited: 1
Paraquat exposure induces Parkinsonism by altering lipid profile and evoking neuroinflammation in the midbrain
Tong Tong, Weixia Duan, Yu‐Dong Xu, et al.
Environment International (2022) Vol. 169, pp. 107512-107512
Open Access | Times Cited: 33
Tong Tong, Weixia Duan, Yu‐Dong Xu, et al.
Environment International (2022) Vol. 169, pp. 107512-107512
Open Access | Times Cited: 33
Serum-Based Lipid Panels for Diagnosis of Idiopathic Parkinson’s Disease
Lina A. Dahabiyeh, Refat M. Nimer, Maha Rashed, et al.
Metabolites (2023) Vol. 13, Iss. 9, pp. 990-990
Open Access | Times Cited: 17
Lina A. Dahabiyeh, Refat M. Nimer, Maha Rashed, et al.
Metabolites (2023) Vol. 13, Iss. 9, pp. 990-990
Open Access | Times Cited: 17
Alpha-Synuclein and Lipids: The Elephant in the Room?
Alessia Sarchione, Antoine Marchand, Jean‐Marc Taymans, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2452-2452
Open Access | Times Cited: 40
Alessia Sarchione, Antoine Marchand, Jean‐Marc Taymans, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2452-2452
Open Access | Times Cited: 40
Alteration in the Cerebrospinal Fluid Lipidome in Parkinson’s Disease: A Post-Mortem Pilot Study
Joaquín Fernández‐Irigoyen, Paz Cartas‐Cejudo, Marta Iruarrizaga‐Lejarreta, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 491-491
Open Access | Times Cited: 39
Joaquín Fernández‐Irigoyen, Paz Cartas‐Cejudo, Marta Iruarrizaga‐Lejarreta, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 491-491
Open Access | Times Cited: 39
Defining a Lewy Body: Running Up the Hill of Shifting Definitions and Evolving Concepts
Tim E. Moors, Dragomir Milovanović
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 1, pp. 17-33
Open Access | Times Cited: 5
Tim E. Moors, Dragomir Milovanović
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 1, pp. 17-33
Open Access | Times Cited: 5
Alpha-Synuclein and the Endolysosomal System in Parkinson’s Disease: Guilty by Association
Maxime Teixeira, Razan Sheta, Walid Idi, et al.
Biomolecules (2021) Vol. 11, Iss. 9, pp. 1333-1333
Open Access | Times Cited: 31
Maxime Teixeira, Razan Sheta, Walid Idi, et al.
Biomolecules (2021) Vol. 11, Iss. 9, pp. 1333-1333
Open Access | Times Cited: 31
The potential role of glucose metabolism, lipid metabolism, and amino acid metabolism in the treatment of Parkinson's disease
Hangzhen Li, Fancai Zeng, Cancan Huang, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 2
Open Access | Times Cited: 12
Hangzhen Li, Fancai Zeng, Cancan Huang, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 2
Open Access | Times Cited: 12
Acute lipid droplet accumulation induced by the inhibition of the phospholipase DDHD2 does not affect the level, solubility, or phosphoserine-129 status of α-synuclein
Magdalena M. Bolsinger, Tim E. Moors, Lisa Brontesi, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access
Magdalena M. Bolsinger, Tim E. Moors, Lisa Brontesi, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access
Lipid Homeostasis and Its Links With Protein Misfolding Diseases
Michele Vendruscolo
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 17
Michele Vendruscolo
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 17
pH Effects Can Dominate Chemical Shift Perturbations in 1H,15N-HSQC NMR Spectroscopy for Studies of Small Molecule/α-Synuclein Interactions
Anil K. Pandey, Caroline R. Buchholz, Noah Nathan Kochen, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 4, pp. 800-808
Open Access | Times Cited: 10
Anil K. Pandey, Caroline R. Buchholz, Noah Nathan Kochen, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 4, pp. 800-808
Open Access | Times Cited: 10
Therapeutic genetic variation revealed in diverse Hsp104 homologs
Zachary M. March, Katelyn Sweeney, Hanna Kim, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 26
Zachary M. March, Katelyn Sweeney, Hanna Kim, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 26
LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson’s disease and dementia with Lewy bodies
Martyna M. Grochowska, Ana Carreras Mascaro, Valerie Boumeester, et al.
Acta Neuropathologica (2021) Vol. 142, Iss. 1, pp. 117-137
Open Access | Times Cited: 22
Martyna M. Grochowska, Ana Carreras Mascaro, Valerie Boumeester, et al.
Acta Neuropathologica (2021) Vol. 142, Iss. 1, pp. 117-137
Open Access | Times Cited: 22
Navigating α‐Synuclein Aggregation Inhibition: Methods, Mechanisms, and Molecular Targets
Maksym Galkin, Anastasiia Priss, Yevhenii Kyriukha, et al.
The Chemical Record (2023) Vol. 24, Iss. 2
Closed Access | Times Cited: 7
Maksym Galkin, Anastasiia Priss, Yevhenii Kyriukha, et al.
The Chemical Record (2023) Vol. 24, Iss. 2
Closed Access | Times Cited: 7
Arylsulfatase A (ASA) in Parkinson’s Disease: From Pathogenesis to Biomarker Potential
Efthalia Angelopoulou, Yam Nath Paudel, Chiara Villa, et al.
Brain Sciences (2020) Vol. 10, Iss. 10, pp. 713-713
Open Access | Times Cited: 15
Efthalia Angelopoulou, Yam Nath Paudel, Chiara Villa, et al.
Brain Sciences (2020) Vol. 10, Iss. 10, pp. 713-713
Open Access | Times Cited: 15
High expression of VTA1 is an adverse prognostic factor in lung adenocarcinoma
Xingang Sun, Rui‐Xin Wu, Xinjun Guan, et al.
Cellular and Molecular Biology (2024) Vol. 70, Iss. 1, pp. 46-55
Open Access | Times Cited: 1
Xingang Sun, Rui‐Xin Wu, Xinjun Guan, et al.
Cellular and Molecular Biology (2024) Vol. 70, Iss. 1, pp. 46-55
Open Access | Times Cited: 1
The synaptic vesicle cluster as a controller of pre‐ and postsynaptic structure and function
Sofiia Reshetniak, Cristian A. Bogaciu, Stefan Bonn, et al.
The Journal of Physiology (2024)
Open Access | Times Cited: 1
Sofiia Reshetniak, Cristian A. Bogaciu, Stefan Bonn, et al.
The Journal of Physiology (2024)
Open Access | Times Cited: 1
HDL Accessory Proteins in Parkinson’s Disease—Focusing on Clusterin (Apolipoprotein J) in Regard to Its Involvement in Pathology and Diagnostics—A Review
Izabela Berdowska, M. Matusiewicz, Małgorzata Krzystek‐Korpacka
Antioxidants (2022) Vol. 11, Iss. 3, pp. 524-524
Open Access | Times Cited: 7
Izabela Berdowska, M. Matusiewicz, Małgorzata Krzystek‐Korpacka
Antioxidants (2022) Vol. 11, Iss. 3, pp. 524-524
Open Access | Times Cited: 7
Emerging concepts in synucleinopathies
Tiago F. Outeiro
Acta Neuropathologica (2021) Vol. 141, Iss. 4, pp. 469-470
Open Access | Times Cited: 8
Tiago F. Outeiro
Acta Neuropathologica (2021) Vol. 141, Iss. 4, pp. 469-470
Open Access | Times Cited: 8
